VANCOUVER, Washington, March 16, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 ...
Taysha Gene Therapies, Inc. achieved positive updated data from Part A of the phase 1/2 REVEAL study using TSHA-102 to treat patients with Rett Syndrome. Alignment gained with FDA on IND amendments to ...
Roche, a global pioneer in pharmaceuticals and diagnostics, announced that the US Food and Drug Administration (FDA) has provided approval to initiate collection and testing of blood samples for ...
NEW YORK, June 22, 2011 (GLOBE NEWSWIRE) -- Ventrus BioSciences, Inc. (Nasdaq:VTUS) announced today that it has received a response from the U.S. Food and Drug Administration (FDA) to its last Special ...
The U.S. Army Medical Materiel Development Activity's Division's Specialized MEDCOM [U.S. Army Medical Command] Response Capabilities -- Investigational New Drug, or SMRC-IND team is a deployable ...
—Open Innovation Drug Developer Transparency Life Sciences Gains Clearance to Proceed with Phase II Trial of Lisinopril as Adjunctive Therapy in Multiple Sclerosis— —Groundbreaking Crowdsourced ...
Coronavirus Can Quickly Progress to Severe Pneumonia and Even Death Due to Immune Hyperactivity Including Acute Respiratory Distress Syndrome (ARDS); CytoDyn's Trial Focuses on Patients Who Develop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback